Max Robotics — Global Service Robot Directory + US Certification

About

Kevin Pinto is a urologic surgeon and researcher whose work centers on improving surgical outcomes in robotic prostate cancer surgery, with a particular focus on reducing postoperative complications and understanding the role of surgical training. His most impactful contribution comes from the PLUS trial, a landmark study demonstrating that a peritoneal iliac flap significantly reduces lymphocele formation after robotic radical prostatectomy—a finding with direct clinical implications for patient recovery. This work has garnered 17 citations since 2022, underscoring its relevance in the field. Pinto has also critically examined the impact of urology resident involvement during robotic-assisted laparoscopic radical prostatectomy, showing that trainee participation does not compromise intraoperative, long-term oncologic, or functional outcomes. This 2019 study, with 15 citations, provides valuable reassurance for teaching hospitals balancing education with patient safety. Through these contributions, Pinto has advanced both the technical refinement of robotic prostatectomy and the evidence base for surgical training, making him a notable voice in contemporary urologic oncology.